Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
13.73
0.00 (0.00%)
At close: Aug 12, 2026, 4:00 PM EDT
13.72
-0.01 (-0.07%)
After-hours: Aug 12, 2026, 4:15 PM EDT

Carlsmed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
375329--
Market Cap Growth
11.14%---
Enterprise Value
307.56236.0900
Last Close Price
13.7312.35--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
PS Ratio
5.846.50--
PB Ratio
4.443.32--
P/TBV Ratio
4.141.78--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
4.784.67--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.250.170.65-3.36
Net Debt / Equity Ratio
-0.80-0.930.33-0.09
Net Debt / EBITDA Ratio
1.763.050.96-0.22
Net Debt / FCF Ratio
1.953.120.90-0.23
Asset Turnover
0.510.560.830.98
Inventory Turnover
7.188.789.076.74
Quick Ratio
8.328.495.331.42
Current Ratio
8.848.875.601.58
Return on Equity (ROE)
-11.48%-47.62%-212.36%686.95%
Return on Assets (ROA)
-31.14%-33.61%-73.27%-132.57%
Return on Invested Capital (ROIC)
-323.79%-615.85%-631.71%-421.85%
Return on Capital Employed (ROCE)
-34.89%-38.50%-97.29%-282.37%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Buyback Yield / Dilution
-496.29%-249.74%-4.62%-
Total Shareholder Return
-496.29%-249.74%-4.62%-
SEC Filings: 10-K · 10-Q